Operating Income: The income after operating expenses.
Arbutus Biopharma Corporation (ABUS) had Operating Income of $-5.96M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.01M |
|
$-5.14M |
|
-- |
|
$1.01M |
|
$6.98M |
|
|
Operating Income |
$-5.96M |
$0.82M |
|
$-5.14M |
|
$-5.14M |
|
$-5.14M |
|
$-5.14M |
|
$-5.14M |
|
$-5.14M |
|
$-5.96M |
|
$-5.95M |
|
197.47M |
|
197.47M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$273.88M |
|
$0.01M |
|
$0.14M |
|
$274.02M |
|
$3.36M |
|
-- |
|
$11.93M |
|
$15.29M |
|
$258.73M |
|
$258.73M |
|
$258.73M |
|
197.63M |
|
| Cash Flow Statement Financials | |
$-14.13M |
|
$0.54M |
|
$14.77M |
|
$18.01M |
|
$19.17M |
|
$1.16M |
|
$2.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
81.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-588.17% |
|
-588.17% |
|
-- |
|
-507.20% |
|
-507.20% |
|
$-14.13M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.02M |
|
-1.99% |
|
-1.99% |
|
-1.88% |
|
-1.99% |
|
$1.31 |
|
$-0.07 |
|
$-0.07 |
|